# Invaio Sciences, INC. 401(k) Plan
Source: https://planprovider.pro/companies/invaio-sciences-inc-401k-plan

> Invaio Sciences, INC.&#39;s 401(k) plan: 60 participants, plan year 2024 financials, providers, and benchmarks from Form 5500.

Form 5500 filing data for plan year 2024.

## Plan Snapshot

- **Plan Sponsor:** Invaio Sciences, INC.

- **Sponsor EIN:** 820792163

- **Sponsor Address:** 75 MOULTON STREET, CAMBRIDGE, MA, 021381127

- **Plan Type:** 401(k)

- **Total Participants:** 60

- **Total Assets:** $4.6M

## Key Plan Design Features

- **Auto-Enrollment:** Yes

- **Auto-Escalation:** No

- **Allows Roth Contributions:** Yes

- **Participant Loans:** No

- **Participant-Directed Investments:** Yes

- **ERISA Section 404(c) Fiduciary Safe Harbor:** Yes

## Plan Financials by Year

| Year|Participants|Total Assets|Employer Contrib.|Employee Contrib.|

| 2024|60|$4.6M|$0|$1.1M|

| 2023|70|$4.0M|$0|$1.3M|

| 2022|122|$2.6M|$0|$978,625|

## Service Providers (Schedule C)

Vendors paid $5,000 or more for services to the plan, ranked by total compensation (direct + indirect fees).

| Provider Name|
Role|
Direct Compensation|
Indirect Compensation|
Total Fees|

| WALDRON H. RAND AND COMPANY, P.C.|Auditor|—|—|$0|

## Plan Fees & Expenses

Annual service provider fees and administrative expenses sourced from DOL Form 5500 filings.

- **Total Service Provider Fees:** $0

### Historical Administrative Expenses

Breakdown of administrative expense categories reported on Form 5500 filings.

| Year|
Total Admin Expenses|
Investment Mgmt Fees|
Contract Admin Fees|
IQPA Audit Fees|
Professional Fees|

| 2024|$21,346|$21,346|—|—|—|

| 2023|$11,148|—|—|—|—|

| 2022|—|—|—|—|—|

## Similar Plans

- [Moma Therapeutics](https://planprovider.pro/companies/moma-therapeutics-401k-plan) — 59 participants

- [Aktis Oncology, INC.](https://planprovider.pro/companies/aktis-oncology-inc-401k-plan) — 62 participants

- [Lifemine Therapeutics, INC.](https://planprovider.pro/companies/lifemine-therapeutics-inc-401k-plan) — 58 participants

- [Xilio Development, INC.](https://planprovider.pro/companies/xilio-development-inc-401k-plan) — 62 participants

- [Sigilon Therapeutics, INC.](https://planprovider.pro/companies/sigilon-therapeutics-inc-401k-plan) — 62 participants

- [Eic Laboratories, INC.](https://planprovider.pro/companies/eic-laboratories-inc-401k-plan) — 64 participants

[View full interactive plan profile on PlanProvider.Pro](https://planprovider.pro/companies/invaio-sciences-inc-401k-plan)

&copy; 2026 PlanProvider.Pro
